85 related articles for article (PubMed ID: 22226042)
1. Mechanistic study on degradation of azelnidipine solution under radical initiator-based oxidative conditions.
Ueyama E; Takahashi F; Ohashi J; Konse T; Kishi N; Kano K
J Pharm Biomed Anal; 2012 Mar; 61():277-83. PubMed ID: 22226042
[TBL] [Abstract][Full Text] [Related]
2. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
[TBL] [Abstract][Full Text] [Related]
3. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
Matsui T; Yamagishi S; Nakamura K; Kikuchi S; Inoue H
Drugs Exp Clin Res; 2005; 31(5-6):215-9. PubMed ID: 16425978
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyl radical-induced oxidation of a phenolic C-linked 2'-deoxyguanosine adduct yields a reactive catechol.
Witham AA; Beach DG; Gabryelski W; Manderville RA
Chem Res Toxicol; 2012 Feb; 25(2):315-25. PubMed ID: 22176608
[TBL] [Abstract][Full Text] [Related]
5. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
6. [Free oxygen radiacals and kidney diseases--part I].
Sakac V; Sakac M
Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
[TBL] [Abstract][Full Text] [Related]
7. A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates.
Nakano K; Egashira K; Tada H; Kohjimoto Y; Hirouchi Y; Kitajima S; Endo Y; Li XH; Sunagawa K
J Hypertens; 2006 Sep; 24(9):1881-9. PubMed ID: 16915039
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the formation of oxidative damage marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) adduct from the nucleoside 2'-deoxyguanosine by transition metals and suspensions of particulate matter in relation to metal content and redox reactivity.
Valavanidis A; Vlahoyianni T; Fiotakis K
Free Radic Res; 2005 Oct; 39(10):1071-81. PubMed ID: 16298732
[TBL] [Abstract][Full Text] [Related]
9. Antioxidative effects of azelnidipine on mesangial cell proliferation induced by highly concentrated insulin.
Manabe S; Okura T; Fukuoka T; Higaki J
Eur J Pharmacol; 2007 Jul; 567(3):252-7. PubMed ID: 17544393
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
11. pH control of nucleophilic/electrophilic oxidation.
Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
[TBL] [Abstract][Full Text] [Related]
12. Dimethylselenide as a probe for reactions of halogenated alkoxyl radicals in aqueous solution. Degradation of dichloro- and dibromomethane.
Makogon O; Flyunt R; Tobien T; Naumov S; Bonifacić M
J Phys Chem A; 2008 Jul; 112(26):5908-16. PubMed ID: 18540662
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.
Yamamoto E; Lai ZF; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Ito T; Ogawa H; Kim-Mitsuyama S
J Hypertens; 2006 Oct; 24(10):2057-69. PubMed ID: 16957567
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of renal redox status during azelnidipine treatment.
Hirayama A; Ueda A; Oteki T; Nagase S; Aoyagi K; Koyama A
Hypertens Res; 2008 Aug; 31(8):1643-50. PubMed ID: 18971540
[TBL] [Abstract][Full Text] [Related]
15. Peroxynitrite-initiated oxidation of acetoacetate and 2-methylacetoacetate esters by oxygen: potential sources of reactive intermediates in keto acidoses.
Royer LO; Knudsen FS; de Oliveira MA; Tavares MF; Bechara EJ
Chem Res Toxicol; 2004 Dec; 17(12):1725-32. PubMed ID: 15606150
[TBL] [Abstract][Full Text] [Related]
16. Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Ji HJ; Zhou XH; Zhu YB; Fan HW; Xiao DW; Hu Q
Pharmazie; 2008 Aug; 63(8):568-70. PubMed ID: 18771003
[TBL] [Abstract][Full Text] [Related]
17. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
18. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
Nakamura K; Yamagishi S; Inoue H
Med Hypotheses; 2005; 65(1):155-7. PubMed ID: 15893134
[TBL] [Abstract][Full Text] [Related]
19. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
[TBL] [Abstract][Full Text] [Related]
20. A stability indicating LC method for zolmitriptan.
Rao BM; Srinivasu MK; Sridhar G; Kumar PR; Chandrasekhar KB; Islam A
J Pharm Biomed Anal; 2005 Sep; 39(3-4):503-9. PubMed ID: 15899567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
